1. Appiah-Ankam J, Hunter JM. Pharmacology of neuromuscular blocking drugs. Contin Educ Anaesth Crit Care Pain. 2004;4(1):2–7.
2. Bowman WC. Neuromuscular block. Br J Pharmacol. 2006;147(Suppl 1):S277–86.
3. Butterworth JF, IV, Mackey DC, Wasnick JD. Butterworth JF, IV, Mackey DC, Wasnick JD, Butterworth, JF, IV, et al. Chapter 11. Neuromuscular blocking agents. In: Butterworth JF, IV, Mackey DC, Wasnick JD. Butterworth JF, IV, Mackey DC, Wasnick JD, Butterworth, JF, IV, et al. editors. Morgan & Mikhail’s Clinical Anesthesiology, 5e. New York, NY: McGraw-Hill; 2013. http://accessmedicine.mhmedical.com.ezp-prod1.hul.harvard.edu/content.aspx?bookid=564&Sectionid=42800542 . Accessed 10 July 2015.
4. Cooperman L. Succinylcholine induced hyperkalemia in neuromuscular disease. JAMA. 1970;213:1867–71.
5. Kampe S, Krombach JW, Diefenbach C. Muscle relaxants. Best Pract Res Clin Anaesthesiol. 2003;17(1):137–46.